Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Fluticasone propionate; Drug: Salmeterol (as xinafoate)
Sponsor: Intech Biopharm Ltd.
Completed – verified June 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days